2019-003997-25
Prospective randomized study on the feasibility of allogeneic stem cell transplantation in higher-riskmyelodysplastic syndromes, performed upfront or preceded by azacitidine or conventional chemotherapy, according to the BM-blast proportion (ACROBAT trial)

Pdf Stampa

W06 Ricerca farmaco

Titolo/oggetto del contratto di sperimentazione
Prospective randomized study on the feasibility of allogeneic stem cell transplantation in higher-riskmyelodysplastic syndromes, performed upfront or preceded by azacitidine or conventional chemotherapy, according to the BM-blast proportion (ACROBAT trial)
Codice EUDRACT
2019-003997-25
Promotore
Fondazione GIMEMA Franco Mandelli Onlus
Codice del protocollo del promotore
MDS0519
Data di nullaosta
22-02-2023
Data sottoscrizione del contratto
22-02-2023
Data di chiusura
Budget
0,00
Rimborsi
0,00
Totale
0,00
note
Data ultima modifica
02-03-2023 15:23:48

Pincipal investigators

Nome Unità Operativa
Ematologia di Rimini
Nome principal investigator
Simona Tomassetti